真皮填充剂市场 - 预测 2023-2028
市场调查报告书
商品编码
1279586

真皮填充剂市场 - 预测 2023-2028

Dermal Fillers Market - Forecasts from 2023 to 2028

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 165 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

真皮填充剂市场预计将以 8.57% 的复合年增长率增长,从 2021 年的 31.48 亿美元增至 2028 年的 55.97 亿美元。 真皮填充剂是为寻求增强和改变当前面部外观的顾客提供的美容注射。 想要改善面部下垂皮肤(例如脸颊、嘴唇和下巴轮廓)、想要提升面部外观、想要增加质量以及想要塑造对称性的消费者选择真皮填充剂。面部特征。这是一个标准程序 皮肤科医生、医院、医疗水疗中心等出售不同类型的皮肤填充剂。 客户可以立即看到结果,并且可以持续数月至数年,具体取决于所选的真皮填充剂类型。

真皮填充剂因其能够有效逆转患者皮肤衰老迹象并增加目标面部区域的额外体积而广受欢迎。 例如,印度 Ka□□ya Clinic 的 Juvederm 真皮填充剂保证顾客在註射到皮肤后一周内立即看到效果。 晒伤、细纹、眼睛凹陷、皮肤变色和许多其他皮肤瑕疵都是由面部组织体积减少引起的。 通过注射真皮填充剂,使用者可以受益于减少所有此类皮肤缺陷的出现。 除此之外,真皮填充剂有助于增加註射区域的胶原蛋白和弹性蛋白含量,这有利于恢復皮肤健康。 儘管消费者可以选择多种护肤产品和方案,但真皮填充剂提供的效果质量优异,因此,国际真皮填充剂市场的市场规模正在不断扩大。

低风险、非手术、微创手术的增加预计将推动市场增长。

注射到患者皮肤中的真皮填充剂是一种非手术程序。 因此,这是一种微创手术,不需要客户进行整容手术或麻醉即可达到预期效果。 美容协会发布的年度报告强调,到 2021 年,真皮填充手术的数量将达到约 180 万例,而其他皮肤紧緻治疗的数量为 39 万例。 这显示了人们对真皮填充剂的兴趣,因为它们具有多种面部效果和低风险。 因此,考虑到这些推动真皮填充剂市场需求的关键因素,预计在预测期内市场规模将继续增加。

类似美容疗法之间的激烈竞争可能会限制真皮填充剂市场的增长。

除了真皮填充剂之外,还有一些美容手术和皮肤护理服务可以提供与真皮填充剂类似的效果。 肉毒桿菌、射频面部治疗、激光换肤、微针和其他面部復兴治疗。 除了这些现有的方法之外,製药公司和护肤品牌还定期采用新技术和治疗方法进行创新。 例如,美国皮肤科诊所 ForeverSlender Medspa 创新了一种名为 Ultralift 的真皮填充剂的新型非手术替代品。 因此,真皮填充剂其他替代品的存在可能会减缓真皮填充剂市场的扩张。

北美预计将在通用真皮填充剂市场中占据很大份额。

北美国家越来越多的微创美容手术以及皮肤诊所服务和美容导致对真皮填充剂的高需求和消费。 此外,对真皮填充剂和其他美容治疗的需求不断增长,吸引了外国公司进军北美市场。 例如,专注于高端医疗保健和护肤产品的德国公司Amalia宣布在加拿大开设诊所并提供优质真皮填充剂。 此外,北美医疗保健和美容公司正在积极投资新产品的推出,包括真皮填充剂。 例如,美国製药公司艾伯维(AbbVie)正在通过其子公司品牌艾尔建美学(Allergan Aesthetics)开发并推出一系列新的真皮填充剂产品。 因此,考虑到北美真皮填充剂市场快速扩张背后的因素,北美真皮填充剂市场的扩张是可期的。

内容

第 1 章简介

  • 市场概览
  • 市场定义
  • 调查范围
  • 市场细分
  • 货币
  • 先决条件
  • 基准年和预测年时间表

第 2 章研究方法

  • 调查数据
  • 调查设计
  • 验证

第 3 章执行摘要

  • 调查要点

第 4 章市场动态

  • 市场促进因素
  • 市场抑制因素
  • 波特五力分析
  • 行业价值链分析

第 5 章真皮填充剂市场:按产品类型

  • 简介
  • 可生物降解
  • 不可生物降解

第 6 章真皮填充剂市场:按应用分类

  • 简介
  • 脸部线条修正
  • 整容
  • 强化嘴唇
  • 其他

第 7 章真皮填充剂市场:按材料

  • 简介
  • 透明质酸
  • 羟基磷灰石钙
  • 聚-L-乳酸
  • 聚甲基丙烯酸甲酯微球
  • 其他

第 8 章真皮填充剂市场:按最终用户划分

  • 简介
  • 皮肤科诊所
  • 医院
  • 其他

第 9 章真皮填充剂市场:按应用分类

  • 简介
  • 全身

第 10 章真皮填充剂市场:按地区

  • 简介
  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 其他
  • 中东和非洲
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 以色列
    • 其他
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 印度尼西亚
    • 泰国
    • 越南
    • 其他

第 11 章竞争格局与分析

  • 主要公司及战略分析
  • 新兴公司和市场盈利能力
  • 合併、收购、协议与合作
  • 供应商竞争力矩阵

第 12 章公司简介

  • Sinclair
  • Suneva Medical
  • Merz Pharma
  • Abbvie Inc.(ALLEGRAN)
  • Galderma Laboratories, L.P.
  • Croma Pharma
  • Cytophil, Inc.
  • Humedix
  • Prollenium Medical Technologies
简介目录
Product Code: KSI061614648

The dermal fillers market is projected to grow at a CAGR of 8.57%, reaching US$5.597 billion in 2028 from US$3.148 billion in 2021. Dermal fillers are cosmetic injections given to customers seeking to enhance and alter the current appearance of their faces. Dermal fillers are a standard procedure opted for by consumers who wish to reduce the sagging appearance of their facial skin, uplift the facial appearance, increase the mass, or enhance the symmetry of their facial features such as cheeks, lips, and jawlines. An extensive range of different types of dermal fillers is available for consumers through dermatology clinics, hospitals, and medical spas. The customers can notice immediate results and based on the type of dermal filler opted for, the results might be effective for a few months or years.

Dermal fillers are gaining popularity due to their efficiency in restoring the aging signs of the patient's skin and adding extra volume to the targeted facial part. For instance, the Juvederm dermal filler by Kaya Clinic in India guarantees immediate results to its customer within one week of injecting it into the skin. Various skin concern factors such as sun damage, fine lines, wrinkles, sunken eyes, and skin discoloration result from the loss of volume in the face tissues. By injecting dermal fillers, the user can benefit from reducing the appearance of all such skin concerns. Apart from this, the dermal fillers help construct collagen and elastin content in the injected area, which are beneficial to restore the skin's health. Even though there are several skincare products and regimens which can opt for by consumers, the result offered by dermal fillers is of superior quality, due to which the international dermal fillers market is witnessing an increased market size.

An increasing number of low-risk non-surgical, and minimally invasive procedures are expected to boost the market growth.

The dermal fillers injected into the patient's skin are non-surgical procedures. Therefore, it is a minimally invasive procedure that does not require its customer to undergo a cosmetic operation or receive anesthesia to achieve the desired outcome. The annual report released by The Aesthetic Society highlighted that the number of dermal filler procedures in 2021 amounted to approximately 1.8 million, whereas other skin tightening treatment procedures amounted to 0.39 million. This demonstrates interest in dermal fillers owing to their various face enhancement benefits and low-risk features. Therefore, considering these key factors driving demand for the dermal filler market, it can be anticipated that it will continue to expand its market size over the forecast period.

The intense competition offered by similar cosmetic procedures will likely restrain the growth of the dermal fillers market.

Apart from dermal fillers, there are several cosmetic procedures and skin care services that provide similar results as dermal fillers. Botox, radio frequency-based face treatments, laser skin resurfacing method, micro-needling, and other facial revitalization treatments. Apart from these existing methods, pharmaceutical and skincare brands regularly innovate new techniques and treatments. For instance, ForeverSlender Medspa, a skin clinic based in the USA, has innovated a new non-surgical alternative for dermal fillers named Ultralift. Therefore, the existence of other options for derma fillers has the potential to slow down the expansion of the dermal fillers market.

Market Developments

  • In June 2022, Croma Aesthetics Canada Ltd. introduced a new derma filler product, Saypha Volume Plus, with hyaluronic acid as its vital ingredient under its subsidiary brand Hugel Aesthetics. This derma filler targets restoring the original volume of the face.
  • In June 2021, Medytox Inc. expanded its operations to Taiwan and announced a collaboration with Dynamic Medical Technologies Company to manufacture hyaluronic-acid-based dermal fillers.
  • In February 2020, BioScience GmbH, specializing in the manufacture of aesthetic cosmetology products, introduced a new product line consisting of two new derma fillers of varying density levels.

North America is expected to hold a significant share of the universal dermal fillers market.

The increase in minimally-invasive cosmetic procedures across North American countries and the rise in skin clinic services and aesthetics are resulting in high demand and consumption of dermal fillers. Furthermore, the rising need for derma fillers and other cosmetic treatments is attracting branches of foreign companies into the North American market. For instance, Amalian, a German company specializing in high-end healthcare and skincare products, has announced its clinic's launch and superior-quality dermal fillers in Canada. In addition, healthcare and beauty companies in North America are actively investing in launching new products, including dermal fillers. For instance, AbbVie Company, a US-based pharmaceutical company, has been developing and launching new dermal filler product lines through its subsidiary brand, Allergan Aesthetics. Therefore, considering the factors influencing the rapid market growth of dermal fillers in North America, it can be anticipated that North America shall experience expansion in the dermal fillers market.

Market Segmentation

By Product Type

  • Biodegradable
  • Non-biodegradable

By Application

  • Facial Line Correction
  • Face Lift
  • Lip Enhancement
  • Others

By Material

  • Hyaluronic Acid
  • Calcium Hydroxylapatite
  • Poly-L-Lactic Acid
  • Polymethyl-Methacrylate Microspheres
  • Others

By End-User

  • Dermatology Clinics
  • Hospitals
  • Others

By Geography

  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Israel
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Indonesia
    • Thailand
    • Vietnam
    • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline

2. RESEARCH METHODOLOGY

  • 2.1. Research Data
  • 2.2. Research Design
  • 2.3. Validation

3. EXECUTIVE SUMMARY

  • 3.1. Research Highlights

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. DERMAL FILLERS MARKET BY PRODUCT TYPE

  • 5.1. Introduction
  • 5.2. Biodegradable
  • 5.3. Non- Biodegradable

6. DERMAL FILLERS MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Facial Line Correction
  • 6.3. Face Lift
  • 6.4. Lip Enhancement
  • 6.5. Others

7. DERMAL FILLERS MARKET BY MATERIAL

  • 7.1. Introduction
  • 7.2. Hyaluronic Acid
  • 7.3. Calcium Hydroxylapatite
  • 7.4. Poly-L-Lactic Acid
  • 7.5. Polymethyl-Methacrylate Microspheres
  • 7.6. Others

8. DERMAL FILLERS MARKET BY END-USER

  • 8.1. Introduction
  • 8.2. Dermatology Clinics
  • 8.3. Hospitals
  • 8.4. Others

9. DERMAL FILLERS MARKET BY APPLICATION

  • 9.1. Introduction
  • 9.2. Face
  • 9.3. Full body

10. DERMAL FILLERS MARKET BY GEOGRAPHY

  • 10.1. Introduction
  • 10.2. North America
    • 10.2.1. USA
    • 10.2.2. Canada
    • 10.2.3. Mexico
  • 10.3. South America
    • 10.3.1. Brazil
    • 10.3.2. Argentina
    • 10.3.3. Others
  • 10.4. Europe
    • 10.4.1. Germany
    • 10.4.2. France
    • 10.4.3. United Kingdom
    • 10.4.4. Spain
    • 10.4.5. Others
  • 10.5. Middle East And Africa
    • 10.5.1. Saudi Arabia
    • 10.5.2. UAE
    • 10.5.3. Israel
    • 10.5.4. Others
  • 10.6. Asia Pacific
    • 10.6.1. China
    • 10.6.2. Japan
    • 10.6.3. India
    • 10.6.4. South Korea
    • 10.6.5. Indonesia
    • 10.6.6. Thailand
    • 10.6.7. Vietnam
    • 10.6.8. Others

11. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 11.1. Major Players and Strategy Analysis
  • 11.2. Emerging Players and Market Lucrativeness
  • 11.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 11.4. Vendor Competitiveness Matrix

12. COMPANY PROFILES

  • 12.1. Sinclair
  • 12.2. Suneva Medical
  • 12.3. Merz Pharma
  • 12.4. Abbvie Inc. (ALLEGRAN)
  • 12.5. Galderma Laboratories, L.P.
  • 12.6. Croma Pharma
  • 12.7. Cytophil, Inc.
  • 12.8. Humedix
  • 12.9. Prollenium Medical Technologies